BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8855723)

  • 1. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
    Marcellin P; Pouteau M; Martinot M; Boyer N; Castelnau C; Benhamou JP; Erlinger S
    Gastroenterol Clin Biol; 1995 Dec; 19(12):991-1000. PubMed ID: 8729410
    [No Abstract]   [Full Text] [Related]  

  • 3. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 5. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
    Buti M; Esteban R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of chronic viral hepatitis.
    Hoofnagle JH; di Bisceglie AM
    N Engl J Med; 1997 Jan; 336(5):347-56. PubMed ID: 9011789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemiologic studies and treatment of chronic viral hepatitis C].
    Ouzan D
    Med Trop (Mars); 1994; 54(3 Suppl):18-20. PubMed ID: 7596256
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 10. Breakthrough of interferon therapy.
    Scalori A; Ricci A; Bellati G; Colloredo G; Roffi L
    Am J Gastroenterol; 1996 Oct; 91(10):2249-50. PubMed ID: 8855768
    [No Abstract]   [Full Text] [Related]  

  • 11. [Depressive disorders and interferon alpha].
    Hardy P
    Gastroenterol Clin Biol; 1996; 20(3):255-7. PubMed ID: 8763063
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of interferons in hepatology.
    Civeira MP
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():33-4. PubMed ID: 8899691
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disappointing response of chronic C hepatitis to interferon].
    Theodor E; Regev A
    Harefuah; 1997 Mar; 132(6):402-3, 447. PubMed ID: 9153855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
    Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
    [No Abstract]   [Full Text] [Related]  

  • 15. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HCV infection today].
    Vespasiani Gentilucci U; D'Avola D; Picardi A
    Clin Ter; 2003; 154(3):149-50. PubMed ID: 12910802
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C. Understanding the issues.
    Miller SK
    Adv Nurse Pract; 2000 Dec; 8(12):49-50, 87-8. PubMed ID: 12397910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.